Pharmaceuticals
Regent Pacific's Unrealised Gain in Venturex Resources Limited Increased to US$10.74 million
Highlights: Unrealised Gain in Venturex Resources Limited * Regent Pacific's investment in Venturex Resources Limited has increased significantly toUS$10.74 million (approximately HK$83.77 million) and a marked to-market value ofUS$13.13 million (approximately HK$102.41million) on its VXR sha...
2021-05-12 15:04
6750
CStone Announces Acceptance of New Drug Application in Hong Kong for Avapritinib for the Treatment of Adults with Unresectable or Metastatic PDGFRA D842V Mutant Gastrointestinal Stromal Tumor
SUZHOU, China, May 12, 2021 /PRNewswire/ -- CStone Pharmaceuticals ("CStone", HKEX: 2616), a leading biopharmaceutical company focused on researching, developing, and commercializing innovative immuno-oncology therapies and precision medicines, today announced the acceptance of the company's new ...
2021-05-12 14:09
3208
Harbour BioMed Announces Dosing of First Patient in Australia for Phase Ib/IIa Clinical Study of its Next-Generation Anti-CTLA-4 Antibody
CAMBRIDGE, Mass. and ROTTERDAM, Netherlands and SUZHOU, China, May 11, 2021 /PRNewswire/ -- Harbour BioMed ("HBM", HKEX: 02142) today announced the dosing of the first patient in its part 2 of phase I (phase Ib/IIa) clinical study of its next-generation anti-CTLA-4 antibody, where Australian pati...
2021-05-11 18:10
5442
Seegene's Germany subsidiary supports the back-to-school initiative with its COVID-19 tests
* SEEGENE BACKS GERMANY IN ITS EFFORT TO RETURN TO NORMALCY * GERMAN SUBSIDIARY TO SUPPLY COVID-19 DIAGNOSTIC TESTS ENOUGH TO TEST 734,000 PUPILS SEOUL, South Korea, May 11, 2021 /PRNewswire/ -- Seegene Inc. (KQ 096530), a leading molecular diagnostics firm said its German subsidiary, Seegene...
2021-05-11 10:11
1536
Gracell Biotechnologies Appoints Seasoned Gene & Cell Therapy Executive Dr. Jenny (Yajin) Ni as Chief Technology Officer
SUZHOU and SHANGHAI, China, May 10, 2021 /PRNewswire/ -- Gracell Biotechnologies Inc. (NASDAQ: GRCL) ("Gracell"), a global clinical-stage biopharmaceutical company dedicated to developing highly efficacious and affordable cell therapies for the treatment of cancer, today announced the appoin...
2021-05-11 04:01
2409
deCODE genetics - Rounding off the human genome
REYKJAVIK, Iceland, May 10, 2021 /PRNewswire/ -- In a study published today, scientists at deCODE Genetics demonstrate for the first time how long-read DNA sequencing can be applied at population scale to unravel large structural variants that associate with human disease and other traits. In...
2021-05-10 23:00
2252
INOVIO Announces Positive Data from Phase 2 Segment of Clinical Trial Evaluating INO-4800, its COVID-19 DNA Vaccine
PLYMOUTH MEETING, Pa., May 10, 2021 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases, cancer, and HPV-associated diseases, today announced positive safety, tolerability ...
2021-05-10 20:00
3448
Viva Biotech and BioMap Reached a Strategic Collaboration Agreement, To Jointly Accelerate the Early Drug Discovery through AI Technology
SHANGHAI, May 10, 2021 /PRNewswire/ -- Hosted by BioMap and Adock, the first generation of China Biocomputing Conference was successfully launched in Suzhou. The conference is aiming to unite with biotech and IT industry partners to create a multi-party integrated industrial ecosystem, and realiz...
2021-05-10 18:21
2551
Hong Kong Government Endorses INDICAID® in Visitation Resumption Arrangements
HONG KONG, May 10, 2021 /PRNewswire/ -- COVID-19 rapid antigen test (RAT) INDICAID®, developed by Hong Kong biotechnology start-up PHASE Scientific International Limited (PHASE), has been named by the government as one of the designated rapid tests when care homes resume visitation today. The end...
2021-05-10 09:36
3181
Alebund Pharmaceuticals Raises $60 million in Series B Financing Round to Accelerate Its Development of Innovative Drugs and Total Solutions for the Treatment of Renal Diseases
SHANGHAI, May 9, 2021 /PRNewswire/ -- Alebund Pharmaceuticals ("Alebund" or the "Company"), a biopharmaceutical company dedicated to developing innovative therapies for the treatment of renal diseases and related chronic conditions, today announced that it has raised$60 million in its Series B fi...
2021-05-10 08:13
1592
WuXi Biologics Completed Three Acquisitions to Enhance its Global Network
SHANGHAI, May 7, 2021 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a global company with leading open-access biologics technology platforms, announced that it has completed the acquisitions of a Bayer manufacturing facility in Wuppertal,Germany, the Pfizer China ("Pfizer") manufacturing...
2021-05-07 08:30
4941
Nexturn Bio Inc. decided to invest in the development of a new drug pipeline for diabetes treatment using miRNA
SEOUL, South Korea, May 7, 2021 /PRNewswire/ -- Nexturn Bio Inc., a subsidiary of Nexturn Bioscience Co., Ltd. (KOSDAQ:89140), said it has secured a 50% stake in RosVivo Therapeutics Inc., a U.S. new drug developer, as its first investment destination. RosVivo recently developed RSVI-301, a new d...
2021-05-07 07:00
4972
Asieris and BeiGene Enter into Clinical Collaboration to Evaluate Combinations of APL-1202 and Tislelizumab
SHANGHAI, May 6, 2021 /PRNewswire/ -- Asieris Pharmaceuticals ("Asieris") and BeiGene, Ltd. ("BeiGene") today announced that they have entered into a clinical collaboration agreement to evaluate the safety and efficacy of oral APL-1202 in combination with tislelizumab as neoadjuvant therapy in pa...
2021-05-06 20:33
2128
DarwinHealth Announces a Research Collaboration with Bristol Myers Squibb for a Novel Cancer Target Discovery (NCTI) Initiative
NEW YORK, May 6, 2021 /PRNewswire/ -- DarwinHealth, a New York City-based biotechnology company, today announced a scientific research collaboration with Bristol-Myers Squibb Company (NYSE: BMY). The research collaboration, theNovel Cancer Target Initiative (NCTI), employs quantitative systems b...
2021-05-06 20:31
3723
China Jo-Jo Drugstores Hosts Reception for Provincial Government Officials
HANGZHOU, China, May 6, 2021 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD) ("Jo-Jo Drugstores" or "the Company"), a leading online and offline retailer, wholesale distributor of pharmaceutical and other healthcare products and healthcare provider in China, today announced that the C...
2021-05-06 20:30
3180
Moleac Pte Ltd wins SBR National Business Award for Pharmaceuticals
SINGAPORE, May 6, 2021 /PRNewswire/ -- Moleac, a biopharmaceutical company based inSingapore, wins SBR National Business Award for Pharmaceuticals. Moleac is dedicated in finding, developing and commercialising new medicines for the unmet medical needs of patients suffering from central nervous ...
2021-05-06 18:12
1736
Himalaya Therapeutics Announces Appointment of Howe Li as Chief Medical Officer
SAN DIEGO, May 6, 2021 /PRNewswire/ -- Himalaya Therapeutics ("Himalaya"), a clinical-stage biopharmaceutical company focused on development and commercialization inGreater China of a novel class of investigational antibody therapeutics for the treatment of solid tumor cancer, which are based on ...
2021-05-06 10:18
1977
Everest Medicines Receives Orphan Drug Designation from the Ministry of Food and Drug Safety in South Korea for Sacituzumab Govitecan-Hziy in Metastatic Triple-Negative Breast Cancer
SHANGHAI, May 6, 2021 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK), a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products inGreater China and other parts of Asia, announced today that the Ministry of Food and Drug Safety (MFDS) inSouth...
2021-05-06 08:30
3591
Hope Medicine completed US$56 million in Series B financing, strengthening capabilities of global innovation
SHANGHAI, May 6, 2021 /PRNewswire/ -- Recently, the global innovative drug R&D company Hope Medicine Inc. (referred to as "HopeMed") announced the completion of a Series B financingUS$56 million. This round of financing was jointly led by Qiming Venture Partners and Grand Flight Investment. HighL...
2021-05-06 08:00
6249
New Progress in Study on Mechanism of Lianhua Qingwen Capsules for Treatment of COVID-19
BEIJING, May 6, 2021 /PRNewswire/ -- Recently, new progress has been made in the study of the pharmacologically active ingredients and mechanism of Chinese medicine Lianhua Qingwen Capsules in the prevention and treatment of COVID-19. Lianhua Qingwen Capsules is an innovative Chinese medicine deve...
2021-05-06 07:46
6523
Week's Top Stories
Most Reposted
Rocket Travel by Agoda Shares Revealing New Report and Showcases Solution to Transform Hotel Distribution
[Picked up by 314 media titles]
2024-11-21 10:30Rockwell Automation and Microsoft Deliver on a Shared Vision to Accelerate Industrial Transformation
[Picked up by 308 media titles]
2024-11-20 13:29Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
[Picked up by 301 media titles]
2024-11-20 16:30
Travel loyalty programs to focus on offering personalized and flexible customer experiences in 2025
[Picked up by 298 media titles]
2024-11-19 10:42Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
[Picked up by 284 media titles]
2024-11-20 09:00
Most Read
Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
2024-11-20 16:30
8873
Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
2024-11-20 09:00
7709